insidermonkey.com · 4h ago
bullishAbbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?
MedTech investors are facing an increasingly difficult choice.
Theme · Robotics & Autonomy
When the model leaves the data center.
Embodied AI is the next surface area. Tesla's Optimus + FSD are the most ambitious public bet on general-purpose humanoid robotics. Intuitive Surgical is the proof that vertical robotics can build a moat. Industrial automation (ABB, Symbotic) is the boring trade that compounds. The signal here is the lag. Software AI moved first; physical AI is moving now, and the capex implications are larger.
Robotics & Autonomy · 1d avg
+1.87%
7 tickers tracked
Signals (three independent reads)
Fund momentum
0
Funds steady — no meaningful 13F changes this quarter.
Sentiment trend (7d)
+3
9 articles · 33% bullish · split.
Canon citations
1
1 bullish from Andreessen.
What the canon says
“Embodied AI is the next platform. Industrial automation, autonomous transportation, and humanoid robotics are the largest addressable markets.”
Andreessen · bullish
Parallel readings, not a composite score. Composite scoring lands in v3 once each signal validates against subsequent moves.
Constituents · ranked by today’s perf
News in this theme
finance.yahoo.com · 5h ago
bullishDanaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet?
Healthcare investors often face a difficult decision when choosing between companies with very different paths to growth. Some businesses are emerging from temporary industry slowdowns, while others continue compounding through durable competitive advantages. Danaher Corporation (NYSE:DHR) and Intuitive Surgical (NASDAQ:ISRG) illustrate that contrast perfectly. Danaher (NYSE:DHR) is beginning to benefit from improving life sciences spending […]
finance.yahoo.com · 5h ago
bullishThermo Fisher vs. Intuitive Surgical: Which Premium Healthcare Stock Deserves its Valuation?
Premium healthcare stocks often trade at elevated valuations for very different reasons. Thermo Fisher’s (NYSE:TMO) investment case increasingly depends on whether the life sciences industry is emerging from its post-pandemic slowdown, while Intuitive Surgical (NASDAQ:ISRG) continues to hold a dominant position in robotic surgery through factors such as its highly recurring revenue model. Both companies […]
Yahoo · 10h ago
neutralThe $1.7 Trillion Job Apocalypse: Why Investors Can’t Ignore Humanoid Robots
AI has already gutted white-collar tech jobs by the hundreds of thousands, but the next wave targets something far bigger: the physical economy and the wages of workers who never touched a keyboard.
TechCrunch · 11h ago
neutralTechCrunch Mobility: The custom chip driving Waymo’s robotaxi ambitions
Welcome back to TechCrunch Mobility — your central hub for news and insights on the future of transportation.
Yahoo · 17h ago
neutralTesla Stock in 2027: Why I Think It Still Has Room to Run
Tesla has dipped a bit and it faces near-term challenges, but its growing full self-driving, energy, and AI businesses could give it significant long-term growth potential.
Top fund exposures to Robotics & Autonomy
Funds holding the most of this theme
| Fund | Positions | % of portfolio |
|---|---|---|
| ARK InvestPure-play disruptive thesis. AI + robotics + quantum across ARKK, ARKQ, ARKW. | 2 | 7.7% |
| Whale Rock CapitalAI + robotics conviction. Tesla, NVIDIA, Meta core. | 2 | 2.3% |
| Baillie GiffordLong-duration tech. Early NVDA and Tesla holder. | 2 | 2.1% |
| Coatue ManagementAI-heavy hedge fund. Semis + hyperscaler exposure. | 2 | 0.7% |
Constituents drawn from the Bluechip Robotics & Autonomy universe. Fund exposures derived from 13F filings.@BluechipsAI·August 24, 2026